Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by TopicClick for OAS Data Systems and more PubsClick for Data on Specific Drugs of UseClick for Short Reports and FactsClick for Frequently Asked QuestionsClick for PublicationsClick to send OAS Comments, Questions and RequestsClick for OAS Home PageClick for Substance Abuse and Mental Health Services Administration Home PageClick to Search Our Site

Stimulant Use: 2003

The NSDUH Report: Stimulant Use:  2003

HTML format
PDF format
Highlights:
  • Respondents to SAMHSA's National Survey on Drug Use & Health were asked first about their nonmedical use of three specific classes of stimulants: (1) methamphetamine, Desoxyn®, or Methedrine; (2) Prescription diet pills, such as amphetamines, Benzedrine®, Biphetamine®, Fastin®, or Phentermine®; and (3) Ritalin® or methylphenidate. Then they were asked whether they had used any stimulant from a list: Cylert®, Dexedrine®, Dextroamphetamine, Didrex®, Eskatrol®, Ionamin®, Mazanor®, Obedrin-LA®, Plegine®, Preludin®, Sanorex®, and Tenuate®. If they indicated they had used any of these drugs, they were asked which one(s). Respondents were also asked to name any other prescription stimulants they had used nonmedically. Methamphetamine as recorded by NSDUH includes both prescription preparations (i.e. Desoxyn® and Methedrine) and nonprescription/illicit methamphetamine.
  • In 2003, 20.8 million Americans aged 12 or older (8.8% of that population) had used prescription-type stimulants nonmedically at least once in their lifetime. An estimated 378,000 persons in the United States met the diagnostic criteria for dependence on or abuse of stimulants in the past year.
  • Lifetime use of methamphetamines was reported by 12.3 million (5.2% of the population), prescription diet pills by 8.7 million (3.6%), Ritalin® or methylphenidate by 4.2 million (1.8%), and Dexedrine® by 2.6 million (1.1%).
  • Use of a stimulant in their lifetime varied by race/ethnicity. Whites (10.7%), Native Americans/ Alaska Natives (10.2%), and Native Hawaiians/ Pacific islanders (8.3%) had the highest rates of any stimulant use in their lifetime and Hispanics (5%), Asians (2.8%), and Blacks (2.7%) had the lowest rates.

Other data on stimulants

Other drugs

Other topics

Other OAS publications and services

This Short Report, The NSDUH Report: Stimulant Use:  2003, is based on SAMHSA's  National Survey on Drug Use and Health conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  SAMHSA's National Survey on Drug Use and Health (NSDUH) is the primary source of information on the prevalence, patterns, and consequences of drug and alcohol use and abuse and for selected mental health measures in the general U.S. civilian non institutionalized population, age 12 and older.   SAMHSA's National Survey on Drug Use & Health also provides estimates for drug use and for selected mental health measures by State.

This is the page footer.

This page has been accessed 51561 times since February 4, 2005.

This page was last updated on February 25, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS